Table VI.
Quality Assessment of studies using SIGN guidelines
| SIGN criteria | Chun et al., 2016 | Chowers et al., 2015 | Bessesen et al., 2013 | Hassan et al., 2007 | Montecalvo et al., 2001 | van rijen et al., 2009 | Wassenberg et al., 2011 |
|---|---|---|---|---|---|---|---|
| 1. Is the paper an economic study (i.e. assessing the cost effectiveness of something), or is it just a study of costs? REJECT IF THE LATTER IS TRUE. | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 2. Is the paper relevant to the key question? Analyse using PICO. IF NO REJECT (give reason below). IF YES complete the checklist. | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Section 1: internal validity | |||||||
| 1.1. The study addresses an appropriate and clearly focused question | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 1.2. The economic importance of the question is clear | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 1.3. The choice of study design is justified | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 1.4. All costs that are relevant from the viewpoint of the study are included and are measured and valued appropriately | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 1.5. The outcome measures used to answer the study question are relevant to that purpose and are measured and valued appropriately | Yes | Moderate | Yes | Moderate | Yes | Moderate | Moderate |
| 1.6 If discounting of future costs and outcomes is necessary, it has been performed correctly | No | No | No | No | No | No | No |
| 1.7. Assumptions are made explicit and a sensitivity analysis performed | Yes | Yes | No | No | No | Moderate | No |
| 1.8. The decision rule is made explicit and comparisons are made on the basis of incremental costs and outcomes | Yes | Yes | Yes | No | Moderate | Yes | Moderate |
| 1.9. The results provide information of relevance to policy makers | Yes | Yes | Yes | Yes | Yes | Yes | Moderate |
| Section 2: overall assessment | |||||||
| High | 10 (90.9%) | 9 (81.8%) | 9 (81.8%) | 7 (63.6%) | 8 (72.7%) | 8 (72.7%) | 6 (54.5%) |
| Moderate | 0 (0%) | 1 (9.1%) | 0 (0%) | 1 (9.1%) | 1 (9.1%) | 2 (18.2%) | 3 (27.3%) |
| Low | 1 (9.1%) | 1 (9.1%) | 2 (18.2%) | 3 (27.3%) | 2 (18.2%) | 1 (9.1%) | 2 (18.2%) |
PICO, Patient or Population Intervention Comparison Outcome.